Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Location contact
Clinical Trials Referral Office
CONTACT
Laura Dohrmann
CONTACT
Matthew T. Houdek, M.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06409013
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Clinical Trials Referral Office
CONTACT
Laura Dohrmann
CONTACT
Matthew T. Houdek, M.D.
PRINCIPAL_INVESTIGATOR
PRIMARY OBJECTIVE:
I. To evaluate the use of indocyanine green (ICG) as an intraoperative guide during bone and soft tissue sarcoma resection.
OUTLINE: This is an observational study.
Patients receive ICG infusion prior to undergoing scheduled resection and have medical records reviewed on study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-interventional study
Time frame: Baseline
Intraoperative ICG fluorescence and deduced margins will be analyzed and compared the accuracy to final pathology margins. Negative predictive value will be calculated.
Contact information is provided by the study sponsor or research team.
Clinical Trials Referral Office
CONTACT
Laura Dohrmann
CONTACT
Mayo Clinic
Other
Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07609329
Atrophy, Bone Diseases
Brno, Czechia
View Trial DetailsNCT06129903
Bone Diseases, Bone Neoplasms
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05621668
Bone Diseases, Bone Neoplasms
Houston, Texas, United States
View Trial DetailsNCT05051059
Bone Diseases, Bone Neoplasms
Leuven, Vlaams-Brabant, Belgium
View Trial Details